Howard Marks acquired 5.45 Million Alvotech shares worth $73 Million. That's 1.33% of their equity portfolio (19th largest holding). The investor owns Inf% of the outstanding Alvotech stock. The first Alvotech trade was made in Q2 2022. Since then Howard Marks bought shares two more times and sold shares on two occasions. The stake costed the investor $54.1 Million, netting the investor a gain of 35% so far.